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Poly(A)+ RNA isolated from post-mortem human h~othalami has been used to characterize the poly- 
protein precursors to vasopressin and oxytocin. Translation in a cell-free system and subsequent immuno- 
precipitation with antibodies raised against either vasopressin or neurophysin identified a product of 
M, 19000 (prepro-vasopressin). A second less intense product of M, 16500 was tentatively identified as pre- 
pro-oxytocin. A cDNA library derived from the human hypothalamic poly(A)+ RNA was screened for 
vasopressin and oxytocin-encoding cDNA using heterologous probes; clones encoding the two precursors 
were identified and found to be organized as their rat and bovine counterparts. Northern blot analysis shows 
that the mRNAs for the two prepro-hormones consist of _ 840 (AVP) and _ 700 (OT) nucleotides. 
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1. INTRODUCTION 
Vasopressin and oxytocin are structurally 
related peptide hormones which regulate respec- 
tively the water balance in the distal kidney tubuli 
and uterine contraction during birth. The major 
site of their biosynthesis is the hypothalamus. 
From nucleotide sequence analysis of cDNA clones 
from rat and bovine hypothalami t is known that 
both hormones are synthesized as composite 
precursors, additionally containing their respective 
carrier proteins, the neurophysins. Only the 
vasopressin precursor contains a third unit, a 
glycopeptide [l-3]. 
Analysis of the vasopressin and oxytocin genes 
from rat and cow has shown that both are com- 
posed of 3 distinct exons, each encoding a func- 
tional domain of the precursor [4-61. The hor- 
mones are located on exons A together with their 
signal peptides and the variable N-termini of the 
neurophysins; the major part of the neurophysins 
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are on exons B while exons C contain the variable 
C-termini of the neurophysins as well as the 
glycopeptide in the case of the vasopressin gene. 
Only a single gene for each hormone has been 
found in the 2 species tested. 
No such data were hitherto available for the 
human nonapeptide hormone precursors mostly 
due to the scarcity of suitable hypothalamic tissue. 
Cell-free translation studies using human 
hypothalamic poly(A)+ RNA, however, indicated 
that the size of the prepro-vasopressin precursor 
was similar to that reported from rat and cow (7). 
This was in agreement with protein data which sug- 
gested that high-molecular-mass material with 
vasopressin- and neurophysin-like structure was 
present in extracts from human pituitary [S] and 
lung carcinoma [9]. We present here sequence data 
on the structure of the human vasopressin and ox- 
ytocin precursors. 
2. MATERIALS AND METHODS 
Poly(A)+ RNA was prepared by the 
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guanidinium isothiocyanate method [lo]. Restric- 
tion and other enzymes were purchased from 
Boehringer, Mannheim or from New England 
Biolabs, Schwalbach, FRG. 
2.1. Screening and sequencing 
cDNAs prepared from human hypoth~amic 
poly(A)+ RNA were inserted into the EcoRI site of 
the phage A gtl0 [l 11. The bank (complexity 
130.000) was screened for vasopressin-specific 
plaques by filter hybridization at 65”C, using a rat 
vasopressin cDNA fragment (HindIII-DraI; 
Schmale, unpublished) nick-translated with 
[32P]dCTP to a specific activity of IO8 cpmlpg. 
The oxytocin-specific clones were identified by 
screening the same library sequentially using the 
MnfI fragment (230 bp) and the complete EcoRI 
cDNA insert of the human vasopressin clone (see 
restriction map); the MnlI fragment specifically 
encodes the 3 ‘-end of the vasopressin precursor. 
The oxytocin cDNA should cross-react with the 
EcoRI cDNA but not with the M&I fragment. The 
identified clones were subcloned into plasmid 
pUC9 and sequenced according to Maxam and 
Gilbert [12]. 
2.2. Northern blot analysis 
Total hypothalamic RNA prepared by the 
guanidinium isothiocyanate method was subjected 
to methyl mercuric hydroxide-a~rose gel elec- 
trophoresis [13] and transferred to nylon mem- 
branes (Amersham Hybond N) [14]. 
Northern blot analysis was carried out according 
to Maniatis et al. [IS] with the following modifica- 
tions. Filters were prehybridized in 50% for- 
mamide, 5 x SSPE, 5 x Denhardt’s solution, 
0.5% SDS, lOOpg/ml denatured herring sperm 
DNA and l~~g/rnl poly(A) at 42”C, for at least 
6 h. Hybridization was performed in the same 
solution to which 32P-labelled nick-translated 
probes (spec. act. >4 x 10’ cpm/pg) were added 
( lo7 cpm/ml). 
Hybridization was carried out at 42°C for 16 h. 
Filters were washed at SYC, with 2 changes of 2 x 
SSC, 0.1% SDS, and once each with 1 x SSC, 
0.1% SDS and 0.2 x SSC, 0.1% SDS. They were 
subsequently exposed to Kodak X-Omat AR film 
at - 7O”C, using 2 intensifying screens. 
2.3. Cell-free translation 
Poly(A)+ RNA was translated in a rabbit 
reticulocyte lysate in vitro system, specific transla- 
tion products were immunoprecipitated and 
isolated as described [7]. 
3. RESULTS AND DISCUSSION 
3.1. Cell-free translation products 
When mRNA from human hypothalami was 
translated in a cell-free reticulocyte lysate system a 
precursor of 19 kDa could be precipitated with an- 
tibodies raised against either vasopressin or 
neurophysin (fig. 1). The presumed oxytocin 
precursor migrated with a slightly smaller 
molecular mass of 16.5 kDa (fig.1, arrowhead). 
The low intensity of the oxytocin precursor band 
probably reflects the ratio of the 2 nonapeptide 
mRNAs in the human hypothalamus. 
3.2. Sequence and organization of the hormone 
precursors 
Since cell-free translation showed that the 
poly(A)+ RNA from post-mortem human 
hypothalami was of sufficiently good quality to 
direct the in vitro synthesis of the 2 nonapeptide 
antibodies anti -AVP 
com~tin9 ’ _ + i 
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Fig. 1. Cell-free translation of hypothalamic RNA; A 
and B, RNA prepared from 2 different autopsies. 
Poly(A)+ RNA was translated in a reticulocyte lysate 
system in the presence of [35S]cysteine and im- 
munoprecipitated using antibodies against bovine vaso- 
pressin (AVP) or mixed neurophysin I and II (Np). 
Where indicated IO-25 pg/ml of the competing antigens 
was added prior to immunoprecipitation. Transiation 
products were separated on SDS-polyacrylamide gels 
and subjected to fluorography [7]. a, b, molecular mass 
markers (30 and 14 kDa, respectively). 
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precursors, the same mRNA was used to construct nucleotide sequence for the neurophysin is highly 
a cDNA library in the phage A gtl0. Positive clones conserved, cross-hybridization was expected with 
were identified by using a cDNA insert encoding the human cDNA clone. Of the positively hybridiz- 
the vasopressin precursor from rats. Because the ing recombinant clones 2 were subjected to 
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WL’tiCACtiCA NC AC ‘I’ATGC CGC ‘I‘ TCA T C CTT T GA G CA TC 
AtiCACAtiTCCACAGAGCA~CACTtiC CA TG’KC ACCCC;‘I‘GC C G CA A G A T T 
+--AVP 
-7 
+- Neumphysin II - 
CysI’yrYhr‘til~ASOCySYroAfijClyGlyLySAryAlaHetScfAs~L~uGluLeuA~~~l~CySLSUPrOCySC;lyPC~GlyCly’LySG~yAr~~CyS~~~~ti~~ 
TGCTACTTCCAGAACTGCCCGAGGGGCGGCAAGAGGGCCA’i%TCCGAC~~GACAG~CTCCCCTGCGGCCCCGGGGGC AAAGGCCGCTGCTTCGGG 
A A A CA A T T C G 
A T 
LySA1~CySLl~~e~tilyGl~AryCysAlaAlSA~S~I~etilyVdlCySCySASnAS~til~S~rCySVS~ThrGl~~~~~lu~ySA~~~luVSl~~~H~~ hry 
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G~ycoproieln - 
Ar~AlaAr~~AlabcrAS~,ACySfrAsnALaThrtiinLeuAS~,(;lyProAia~i~AlaLeuL~uL~uAr~~LeuVal~inLeuAlaLI~AlaProG1uProPl~a~~~u 
CGCGCCCGtGCCAGCCACCGC~CACGCAGCTGGA 
TA TCG GA A C AGC TA A T AAM T GG T 
TT A G CT AC T G G GCG 
-7 
rr~~Ala~lnProAsyAla’lyrLna 
CCC(;CCCM;CCCGACeCCTAC~A(;TCCCCG’f~C’~CG’~CCCACCGGCGCtiC’~CTTC(;CQCCC(;CCCC’T(;CACACGtiACAA~AAACCT~‘CtiCCAA~CC 3’ 
TT A CGG T C AT CCCC CA G CT CC f TACAGCAW AAAATAAACTTrTA AAA TGC 
G T G (r GCCCCC CCT C ACC CT C CGCA CA AAAAATA A GTTCI’A GtiC 
Fig.2. (A) Restriction map and sequencing strategy of the human vasopressin precursor cDNA. A, ApI; B, Burt-I; D, 
D&I; E, EcoRI; H, Hphl; M, MrzlI; P, PsfI; T, TaqI; XI, XmaI; XIII, XmaIII. Direction of sequencing is indicated 
by arrows. (B) Nucleotide sequence of the human (H) vasopressin precursor cDNA and its comparison to the rat (R) 
and bovine (B) counterpart. Nucleotides different to the human vasopressin sequence are indicated. The dashed lines 
show the position where the human and rat sequences are shorter by 6 nucleotide residues compared to the bovine 
sequence. Solid lines were drawn where corresponding nucleotides were either absent or not sequenced. 
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nucleotide sequencing (pHV-1, pHV-2), the 
strategy for which is illustrated in fig.2A. The 
nucleotide sequence of the human vasopressin 
precursor compared to that from cow and rat is 
presented in fig.2B. 
According to the nucleotide sequence analysis 
the human prepro-vasopressin consists of 164 
amino acid residues with a molecular mass of 
17423 Da. The precursor starts with a putative 
signal peptide consisting of 19 amino acid residues 
and is separated from the pro-hormone by a small 
amino acid, alanine. 
As in the rat and bovine vasopressin precursors 
the human co~terpart includes the nonapeptide 
hormone immediately adjacent to the signal pep- 
tide. The hormone is separated from the respective 
neurophysin by the triplet Gly-Lys-Arg; the third 
moiety is a glycopeptide, C-terminally located, and 
separated from the neurophysin by a single 
arginine residue. The glycosylation site is predicted 
by the sequence Asn-Ala-Thr. 
In general the deduced amino acid sequences 
agree with those obtained by conventional Edman 
degradation with one exception [16]. The cDNA 
sequence predicts that the human neurophysin of 
the vasopressin precursor contains a valine instead 
of a glycine residue in position 88; this may reflect 
a microheterogeneity or a polymorphism as has 
been reported for the cow 1171, where at position 
89, 70% of neurophysin molecules include an 
isoleucine, the remainder valine. 
The nucleotide sequence for the human 
vasopressin precursor stops short a few nucleotides 
upstream of the first AUG codon. Attempts to 
identify the residual nucleotides by Sr mapping 
have been hampered by the difficulty of obtaining 
adequate quantities of post-modem human 
hypothalamic mRNA. At the 3 ‘-end of the se- 
quence a typical polyadenylation site AATAAA is 
indicated. Inspection and comparison of the 
nucleotide sequence from man, rat and cow show 
a remarkably high degree of sequence homology, 
which is particularly strong in the region encoding 
the conserved part of the neurophysin (fig.2B). 
Also striking is the homology found in the 5 ‘- and 
3 ‘-untranslated regions where in the latter the se- 
quences around the polyadenylation sites are 
highly conserved. 
Rescreening of the phage h gtl0 library with the 
3 ‘-vasopressin specific A4nfl DNA fragment of 
clone pHV-1 indicated that less than 0.01% of the 
recombinant clones encoded the vasopressin 
precursor. Subsequent screening of the library with 
the total cDNA now including the DNA sequence 
encoding the constant neurophysin region revealed 
additional positive signals, attributable to the ox- 
ytocin gene product. The ratio of vasopressin to 
oxytocin-specific clones was approx. 15 : 1. This 
uneven ratio reflects the proportions of the 
magnocellular neurones immunostaining for either 
oxytocin or vasopressin [181 as well as the relative 
peptide levels in extracts of different human brain 
regions [ 191. It would also explain the relatively 
very low intensity of the putative oxytocin precur- 
sor visualized in the cell-free translation experi- 
ment (fig. 1). 
Sequencing of 2 selected oxytocin-specific lones 
(pHO-1, pHG-2) confirmed their identification 
(fig.3), and showed that the human oxytocin 
precursor is organized just as in other species, 
there being no C-terminal glycopeptide moiety as 
in the vasopressin precursors of all mammal 
species studied to date. As in the rat and calf the 
C-terminus of the neurophysin includes an extra 
basic amino acid, arginine, which has presumably 
to be removed by a post-translational cleavage 
process. 
3.3. mRNA analysis 
To determine the length of the vasopressin- and 
- ‘I‘yrLeuPruser~roC~SC;I~SCKtilytilflLySAla~ySGlyS~~GlytilyAryCySAlaValLeuLl~~~uCySCySbe~lZ~OAs,~Gly~yS~lS~l~ 
H -CTACCTGCCGTCGCCCTGCCAGTCC~CAGAAGGCG~~GGGGGccGCTGC~GGTC TTGGGCCTCn;Cn;CAGCCCGGAC~~CAC~C 
H C T c T A A CACGC A 7 T GA 
M cc CCGCC A AG 
ns,,ProAlaCysAS~AlaC;luAla’~tlr~h~~~~Gi~A~l~~~~ 
H CACCCTtiCCn;CGACGCGGAAGCCACCTTCTCCCAGC~~A~~~G~rtiti~~~~tiAA~A~~~‘~~G~G~G~ti~~ - 
It C CT GTTG G tic c c ,‘I% UAW ‘I ‘I’ ‘XAtiC; ‘i”, - 
tl C CTG G A c; CGCC c cc; ‘I‘ ti ti AC; 
Fig.3. Partial nucleotide sequence analysis of the human oxytocin precursor. 
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Fig.4. Northern blot analysis. 2Opg human (H) and 
4Osg bovine (B) hypothalamic total RNA were 
separated on 1.2% agarose gels as described in section 2. 
Hybridization was carried out with 3ZP-tabelled nick- 
translated probes of the complete human vasopressin 
cDNA (hVP-1) or with a PstI/EcoRI fragment of the 
human oxytocin cDNA (see fig.3). 
oxytocin-encoding mRNAs, poly(A)+ RNA from 
post-mortem human hypothalami was separated 
on agarose gel, transferred to nylon filters and 
hybridized to 32P-labelled cDNAs encoding either 
vasopressin (pHV-1) or oxytocin (pHO-1). 
The length of the human vasopressin-encoding 
mRNA was determined to be -840 nucleotides 
which is slightly larger than the corresponding 
bovine one (-780). Since the size predicted from 
the cDNA sequence is -600 nucleotides, the 
poly(A) tail must comprise in excess of 200 A 
residues. The human oxytocin-encoding mRNA 
migrated at -700 nucleotides, being smaller than 
the bovine oxytocin mRNA (-720). The smear 
seen in the lower range of the gel presumably 
results from degradation 
isolated mRNA. 
of the post-mortem 
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